Godwinpeak... 5 posts in 20 min... Breaking down the 'pumper'
I don't see why you need to do that if you are not a real basher... Why don't you just post good info so longs and shorts can make themself a fair decision... Why are you starting with theses bashposts. You are not a retierd lawer are you.
You are a prime example of posting blatent falsehood at its finest declaes. I invite all readers to read your Sep 9 post "Don't forget why you bought AFFY... Much worse product are at the market at this time..." and my reply that outed your purposeful deception. Essentially you posted Aranesp/Mircera percentage of anaphylaxis to total adverse events and said they were more dangerous for anaphylaxis when compared to O's percentage of anaphylaxis to its total patient population. The truth was that O's anaphylaxis rate is 100-fold more than the anaphylaxis rate for Aranesp/Mircera.
O yeah.... Here is the article... As i said did not make it up myself...
"Secondly, foreign substance linked drugs like Omontys are known for anaphylaxis incidents. However, all of them are still in the market because related companies provided very detailed warning labels, pretest protocol and prevention methods. Some of the drugs are even worse than Omontys regarding anaphylaxis incidents. You may find anaphylaxis info for the following foreign substance linked drugs: Mircera, Aranesp, ALDURAZYME, etc.
Mircera is Methoxy Polyethylene Glycol-Epoetin Beta. Methoxy polyethylene glycol-epoetin beta is an ESA, which differs from erythropoietin through formation of a chemical bond between either the N-terminal amino group or the 8-amino group of any lysine present in erythropoietin, predominantly Lys52 and Lys45 and methoxy polyethylene glycol butanoic acid (approximately 30,000 Daltons). This results in a total molecular weight of approximately 60,000 Daltons.
Among 1028 patients experiencing side effects of Mirera, 0.58% of patients have anaphylactic Shock which is almost triple comparing to the Omontys incidents (0.2%).
Aranesp has the active ingredient darbepoetin alfa. It is used to treat anemia and muscular dystrophy. Commonly reported side effects of Aranesp include anemia, pain, aplasia pure red cell, fatigue, and hemoglobin decrease. Aranesp differs from endogenous erythropoietin (EPO) by containing two more N-linked oligosaccharide chains. It is an erythropoiesis-stimulating 165-amino acid protein.
Recently it was reported that patients under Aranesp have anaphylaxis incidents of 0.48%, more than double compared to those injected with Omontys's 0.2%."
No that is what you said. And you think that everything you say is the truth but it isn't. As i said before, do you think i make these things up myself? You only believe yourself and do not listen to anyone else that's dangerous you know. You starting to get blind just to see your own truth. Gltu